Clinical evidence
The Empower+ app, powered by HealthGen's unified biomarker platform, is clinically validated through randomised controlled trials and real-world implementation studies across Singapore's healthcare system.
EMPOWER Trial
997 adults with type 2 diabetes in Singapore randomised to Empower+ app + wearable versus usual care.
Intervention group achieved significantly greater HbA1c reduction and improved patient activation scores.
Both arms showed improvement, with the full intervention achieving higher proportions of clinically significant HbA1c reduction
CARE Trial
400 adults with type 2 diabetes randomised to compare full intervention (app + wearable + CGM + coaching) versus digital-only (app + wearable).
Both arms improved HbA1c, but the full intervention arm showed larger within-arm reductions and a higher proportion achieving clinically significant improvement.
Ready to unify your digital biomarkers?
See how HealthGen can help you ship faster, scale further, and get to insights without rebuilding the stack.